Multi-Functional Injectable Alginate-Collagen Hydrogel for Targeted Therapeutic Delivery

The Stanford team developed a versatile injectable alginate-collagen hydrogel, a significant advancement in regenerative medicine and targeted therapeutic delivery. Designed to be both clinically applicable and cost-effective, this hydrogel bridges the gap between sophisticated lab-based formulations and real-world medical use. Its versatility and biocompatibility make it highly suitable for delivering cells and drugs with precision, offering a practical and high-performance tool for vascular tissue engineering and minimally invasive treatments.

This optimized hydrogel formulation addresses key limitations of previous alginate-based systems,including premature gelation, inconsistent flow properties, and catheter delivery inefficiencies. The optimized formulation ensures smooth and reliable injection and offers several major benefits. It enhances vascular regeneration by promoting endothelial cell growth and angiogenesis. It also enables sustained localized antibiotic delivery for infection prevention and supports reliable catheter-based delivery without clogging. Together, these innovations greatly improve the precision and effectiveness of hydrogel-based treatments in clinical settings.

Stage of Development: Research - in vitro